Definition of Hemodynamic in Acute Pulmonary Embolism
In the context of acute pulmonary embolism, "hemodynamic" refers to the status of blood flow and circulatory function, specifically whether the patient maintains adequate cardiac output and systemic perfusion. 1
Hemodynamic Instability: The Critical Definition
Hemodynamic instability in acute PE is precisely defined by the 2019 ESC Guidelines and delineates high-risk PE requiring emergency intervention. A patient is hemodynamically unstable if they present with ANY ONE of the following at presentation 1:
Three Defining Criteria:
Cardiac arrest requiring cardiopulmonary resuscitation
Obstructive shock with:
- Systolic BP < 90 mmHg OR vasopressors required to maintain BP
- AND end-organ hypoperfusion (altered mental status, cold/clammy skin, oliguria/anuria, increased serum lactate)
Persistent hypotension:
- Systolic BP < 90 mmHg OR systolic BP drop ≥40 mmHg
- Lasting longer than 15 minutes
- NOT caused by new-onset arrhythmia, hypovolemia, or sepsis
Pathophysiology of Hemodynamic Compromise
The hemodynamic consequences stem from acute right ventricular (RV) failure 1, 2. When pulmonary vascular resistance increases abruptly due to embolic obstruction, the thin-walled RV cannot generate sufficient pressure to maintain pulmonary flow. This triggers a cascade:
- RV dilatation → tricuspid insufficiency
- Decreased RV output → reduced left ventricular preload → decreased cardiac output
- RV ischemia from increased oxygen demand and decreased coronary perfusion
- Systemic hypotension → further RV compromise → potential circulatory collapse and death
Critical Context for Apixaban Use
The FDA label explicitly contraindicates initiating apixaban in hemodynamically unstable PE patients 3. The label states: "Initiation of apixaban tablets are not recommended as an alternative to unfractionated heparin for the initial treatment of patients with PE who present with hemodynamic instability or who may receive thrombolysis or pulmonary embolectomy."
Clinical Algorithm for Your Patient:
If your patient with recent acute PE treated with apixaban was hemodynamically STABLE at presentation:
- Apixaban is appropriate and effective 4
- Continue as prescribed for minimum 3 months 5
- Monitor for recurrence and bleeding
If your patient was hemodynamically UNSTABLE at presentation:
- They should have received unfractionated heparin initially, not apixaban 3
- Apixaban may be appropriate for transition after stabilization
- These patients require vasopressor/inotropic support 6 and consideration for reperfusion therapy
Key Clinical Pitfall
Do not confuse radiological severity with hemodynamic severity 7. A patient can have extensive clot burden on CT (affecting multiple lobes) but remain hemodynamically stable. Conversely, smaller emboli in patients with pre-existing cardiopulmonary disease may cause hemodynamic instability. The hemodynamic status—not the imaging appearance—determines risk category and treatment urgency 1.
Hemodynamic stability is assessed clinically at the bedside through blood pressure, perfusion status, and need for vasopressor support—not through imaging studies alone.